Trust Company of Oklahoma’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,587
Closed -$224K 129
2018
Q4
$224K Sell
3,587
-3,742
-51% -$262K 0.12% 118
2018
Q3
$566K Sell
7,329
-59
-0.8% -$4.46K 0.26% 72
2018
Q2
$523K Sell
7,388
-929
-11% -$65.6K 0.26% 72
2018
Q1
$627K Sell
8,317
-144
-2% -$11.4K 0.3% 69
2017
Q4
$606K Sell
8,461
-270
-3% -$20.5K 0.29% 70
2017
Q3
$707K Sell
8,731
-147
-2% -$11.2K 0.35% 63
2017
Q2
$628K Buy
8,878
+294
+3% +$19.6K 0.32% 65
2017
Q1
$583K Buy
8,584
+958
+13% +$67.4K 0.3% 68
2016
Q4
$546K Buy
7,626
+1,159
+18% +$86.1K 0.29% 68
2016
Q3
$512K Buy
6,467
+593
+10% +$48.2K 0.28% 68
2016
Q2
$490K Buy
5,874
+435
+8% +$38.6K 0.27% 64
2016
Q1
$500K Buy
+5,439
New +$490K 0.28% 61

Other funds holding GILD

Trust Company of Oklahoma's GILD Position: Q1 2019 in Review

Trust Company of Oklahoma sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 3,587 shares — an estimated $224K sold.

Trust Company of Oklahoma first reported a position in GILD in Q1 2016 and held it in 12 quarters. The position peaked at $707K in Q3 2017. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Trust Company of Oklahoma reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Trust Company of Oklahoma sold 3,587 Gilead Sciences shares in Q1 2019, an estimated $224K.
  • Trust Company of Oklahoma first reported a position in Gilead Sciences in Q1 2016 and held it in 12 quarters.
  • Trust Company of Oklahoma's Gilead Sciences position peaked at $707K in Q3 2017.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Trust Company of Oklahoma's 13F filing for Q1 2019, filed 10 Apr 2019.